Medtronic says FY26 Impact Report shows 68% cut in Scope 1 and 2 emissions intensity vs FY20 baseline
Bitget2026/10/06 14:08Medtronic released its fiscal 2026 Impact Report, citing more than 82 million patients served worldwide. R&D investment totaled $2.9 billion, supporting more than 315 product approvals in major markets, including FDA clearance of the Hugo surgical robot. Quality nonconformances fell 70% through expanded First Time Quality programs across manufacturing, distribution, and service operations. Scope 1 and 2 emissions intensity dropped 68% versus the fiscal 2020 baseline; renewable electricity sourcing rose to 65%. Supplier engagement on Scope 3 targets increased to about 18%; packaging materials fell by 230 tonnes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.
- Medtronic released its fiscal 2026 Impact Report, citing more than 82 million patients served worldwide.
- R&D investment totaled $2.9 billion, supporting more than 315 product approvals in major markets, including FDA clearance of the Hugo surgical robot.
- Quality nonconformances fell 70% through expanded First Time Quality programs across manufacturing, distribution, and service operations.
- Scope 1 and 2 emissions intensity dropped 68% versus the fiscal 2020 baseline; renewable electricity sourcing rose to 65%.
- Supplier engagement on Scope 3 targets increased to about 18%; packaging materials fell by 230 tonnes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wedbush: Hard drive supply falls short of demand, Seagate (STX.US) and Western Digital (WDC.US) earnings reports may bring surprises
Wedbush reiterated its "outperform" ratings for Seagate and Western Digital, setting target prices at $1,000 and $650, respectively.
JPMorgan maintains Underweight rating on Nike (NKE.US): Deep in adjustment pains, performance pressures may persist until fiscal year 2028
Recently, JPMorgan released a U.S. equity research report on Nike. The research team participated in a face-to-face meeting with Nike's new CFO, Denton, updated profit assumptions based on management statements, and maintained an “underweight” investment rating on Nike.
Piper Sandler lowers Meta's target price to $850
Crypto prices
More
